A Brucella ovis antigenic complex bearing poly-ε-caprolactone microparticles confer protection against experimental brucellosis in mice

Vaccine

Volumn 19, Issue 30, 2001, Pages 4099-4106

  Murillo, M ^a   Grillo M J ^b   Rene J ^a   Marin C M ^b   Barberan M ^b   Goni M M ^a   Blasco, J M ^b   Irache, J M ^a   Gamazo, C ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto Agroalimentario de Aragón IA2   (Spain)

Author keywords

Brucellosis; Microparticles; Poly caprolactone

Indexed keywords

BRUCELLA OVIS VACCINE; BRUCELLA VACCINE; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 4; POLYCAPROLACTONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA OVIS; BRUCELLOSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BRUCELLA; BRUCELLOSIS; FEMALE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; POLYESTERS; SHEEP;

EID: 0035919548     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00177-3     Document Type: Article

References (38)

1. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats
2. Experimental infection in pregnant cattle with the vaccine Brucella abortus strain RB51: Pathologic, bacteriologic and serological findings
3. Brucella melitensis Rev.1 vaccine as a cause of human brucellosis
4. Reporte de primer caso de primer caso humano de aislamiento y tipificacón de Brucella abortus RB51
5. Effectivity of Rev 1 vaccine in rams against Brucella ovis infection
6. The persistence of antibodies against Brucella ovis and Brucella abortus in rams following vaccination: A field study
7. Brucella ovis
8. Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice
9. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4
10. Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies
11. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation
12. Derivation and evaluation of the rough rfbk brucellosis vaccine in cattle
13. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams
14. Comparison of lipopolysaccharide and outer membrane protein-lipopolysaccharide extracts in an enzime-linked immunosorbent assay for the diagnosis of Brucella ovis infection
15. Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis
16. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines
17. New advances in microsphere-based single-dose vaccines
18. Tissue response to biodegradable injectable microcapsules
19. Revisting PLA/PLGA microspheres: An analysis of their potential in parenteral vaccination
20. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev.1 and Brucella abortus B19 vaccines
21. Comparative analysis of proteins extracted by hot saline or release spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis
22. Protein measurement with the Folin phenol reagent
23. Studies on the Gram-negative cell-wall. I. Evidence for the role of 2-keto-3-deoxy-octonate in the lipopolysaccharide of Salmonella typhimurium
24. A new technique to efficiently to entrap leuprolide acetate into microspheres of polylactic acid or copoly(lactic/glycolic) acid
25. Measurement of protein using bicinchoninic acid
26. Differential activation of Brucella- reactive CD4 + T cells by Brucella infection or immunization with antigenic extracts
27. Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers
28. Comparison of polyclonal, monoclonal and protein G peroxidase conjugates in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis in sheep
29. Comparison of counterimmunoelectroforesis with oter serological tests in the diagnosis of human brucellosis
30. Efficicacy of Brucella melitensis Rev 1 vaccine against Brucella ovis infection in rams
31. Comparative protection of mice against virulent and attenuated starins of Brucella abortus by passive transfer of immune T cells or serum
32. Endogenous gamma interferon mediates resistance to Brucella abortus infection
33. Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice
34. Effects of cytokines on intracellular growth of Brucella abortus
35. Th1 cell and Th2 cell: Different patterns of lymphokine secretion lead to different functional properties
36. Controlled vaccine release in gut-associated lymphoid tissues. I. Orally administered biodegradable microparticles target the Peyer's patches
37. Influence of various technological parameters on the preparation of spray-dried poly(ε-caprolactone) microparticles containing a model antigen
38. Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery